CorNeat Vision aims to improve the lives of affected people by offering innovative, permanent, convenient and affordable solutions by leveraging its unique technology and R&D capabilities. We have successfully developed an artificial cornea (the CorNeat KPro) and an artificial sclera (the CorNeat EverPatch), which will improve the quality of life for many in need. Our first two products have successfully passed all pre-clinical requirements and will enter the clinical phase in 2020.
While our first devices enter the clinical phase, R&D and financial resources are focused on new applications, which will significantly expand the ophthalmic indications we target and evaluate the use of associated technology in additional fields.
Our permanent ophthalmic implants utilize advanced cell technology and nanoscale chemical engineering to mimic cellular and subcellular structures, stimulating cellular growth and complete integration with surrounding tissue.
We combine innovative ideas and tissue integration capability to fabricate solutions, which serve to replace damaged biological organs and tissue and repair their function.
CorNeat Vision is an innovative ophthalmic medical device company with an overarching mission of promoting human health, sustainability and equality worldwide.
CorNeat Vision’s patented implants and corresponding procedures prevent and reverse blinding disease processes by mending and replacing damaged tissue, while mimicking its function.
The CorNeat Vision lineup of biomimetic ophthalmic implants blend novel bio-integration technology with innovative ideas to create ground breaking solutions that address unmet ophthalmic needs. Our products biomechanically incorporate with resident ocular tissue providing safe, aesthetic and long-lasting remedies for corneally blind patients and those suffering from severe glaucoma. These include the CorNeat KPro (artificial cornea), the CorNeat EverPatch (synthetic non-degradable scleral patch) and the CorNeat eShunt (Glaucoma drainage device).